DEXCOM, INC. Interest Expense Nonoperating
DEXCOM, INC. (DXCM) reported Interest Expense Nonoperating of $3.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-07-30
- DEXCOM, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $3.00M, a 36.17% decline year-over-year.
- DEXCOM, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $3.10M, a 34.04% decline year-over-year.
- DEXCOM, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $4.20M, a 14.29% decline year-over-year.
- DEXCOM, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $4.70M, a 0.00% change year-over-year.
- DEXCOM, INC. interest expense nonoperating for fiscal 2025 was $18.30M, a 3.68% decline from fiscal 2024.
- DEXCOM, INC. interest expense nonoperating for fiscal 2024 was $19.00M, a 6.40% decline from fiscal 2023.
- DEXCOM, INC. interest expense nonoperating for fiscal 2023 was $20.30M, a 9.14% increase from fiscal 2022.
- DEXCOM, INC. interest expense nonoperating for fiscal 2022 was $18.60M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.00M 10-Q · filed 2026-07-30 | $6.10M 10-Q · filed 2026-07-30 | $10.30M derived: sum of 3 quarters · filed 2026-07-30 | $15.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $3.10M 10-Q · filed 2026-04-30 | $7.30M derived: sum of 2 quarters · filed 2026-04-30 | $12.00M derived: sum of 3 quarters · filed 2026-04-30 | $16.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $4.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $8.90M derived: sum of 2 quarters · filed 2026-02-12 | $13.60M derived: sum of 3 quarters · filed 2026-07-30 | $18.30M 10-K · filed 2026-02-12 |
| 2025-09-30 | $4.70M 10-Q · filed 2025-10-30 | $9.40M derived: sum of 2 quarters · filed 2026-07-30 | $14.10M 10-Q · filed 2025-10-30 | $19.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $4.70M 10-Q · filed 2026-07-30 | $9.40M 10-Q · filed 2026-07-30 | $14.30M derived: sum of 3 quarters · filed 2026-07-30 | $19.00M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $4.70M 10-Q · filed 2026-04-30 | $9.60M derived: sum of 2 quarters · filed 2026-04-30 | $14.30M derived: sum of 3 quarters · filed 2026-04-30 | $19.10M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $9.60M derived: sum of 2 quarters · filed 2026-02-12 | $14.40M derived: sum of 3 quarters · filed 2026-02-12 | $19.00M 10-K · filed 2026-02-12 |
| 2024-09-30 | $4.70M 10-Q · filed 2025-10-30 | $9.50M derived: sum of 2 quarters · filed 2025-10-30 | $14.10M 10-Q · filed 2025-10-30 | $19.00M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $4.80M 10-Q · filed 2025-07-30 | $9.40M 10-Q · filed 2025-07-30 | $14.30M derived: sum of 3 quarters · filed 2026-02-12 | $19.20M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | $4.60M 10-Q · filed 2025-05-01 | $9.50M derived: sum of 2 quarters · filed 2026-02-12 | $14.40M derived: sum of 3 quarters · filed 2026-02-12 | $20.30M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | $4.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $9.80M derived: sum of 2 quarters · filed 2026-02-12 | $15.70M derived: sum of 3 quarters · filed 2026-02-12 | $20.30M 10-K · filed 2026-02-12 |
| 2023-09-30 | $4.90M 10-Q · filed 2024-10-24 | $10.80M derived: sum of 2 quarters · filed 2024-10-24 | $15.40M 10-Q · filed 2024-10-24 | |
| 2023-06-30 | $5.90M 10-Q · filed 2024-07-25 | $10.50M 10-Q · filed 2024-07-25 | ||
| 2022-12-31 | $18.60M 10-K · filed 2025-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |